Merck & Co., Inc.: 13F holdings
CIK 3101582026Q2
| Positions | 13 |
|---|---|
| Reported value | $526.4m |
| Filed | 2026-08-07 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PERSONALIS INC | 14,044,943 | $188.2m | 35.8% |
| MRNA MODERNA INC | 2,308,190 | $161.6m | 30.7% |
| KYMR KYMERA THERAPEUTICS INC | 772,165 | $88.5m | 16.8% |
| AKTIS ONCOLOGY INC | 952,844 | $30.7m | 5.8% |
| EIKON THERAPEUTICS INC | 1,666,666 | $21.7m | 4.1% |
| ENTRADA THERAPEUTICS INC | 1,739,768 | $12.8m | 2.4% |
| SUTRO BIOPHARMA INC | 272,351 | $9.0m | 1.7% |
| ALEC ALECTOR INC | 3,545,719 | $7.1m | 1.4% |
| EVAXION BIOTECH A/S | 1,214,126 | $3.8m | 0.7% |
| VIRIDIAN THERAPEUTICS INC | 93,414 | $1.7m | 0.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="310158")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.